News Bulletin

Personalized medicine seeks to adjust prevention, diagnosis, and treatment to each patient’s distinct biological makeup, environmental context, and lifestyle habits, and over the past decade this vision has steadily shifted into routine practice, influencing how therapies are created and how clinical trials take shape. Progress in genomics, data science, and digital health continues to drive this evolution, while regulatory bodies and healthcare institutions adapt to encourage more precise, individualized, and patient-focused research frameworks.Genomics and Multi-Omics as Cornerstones of ProgressThe steep drop in genome sequencing costs, paired with the expanding use of multi-omics approaches, has significantly transformed personalized medicine.Genomics: Whole genome…

Augmented reality glasses and spatial computing platforms are shifting from specialized experimental gear to indispensable computing tools, a change driven by advances in hardware miniaturization, artificial intelligence, connectivity, and mature software ecosystems, all coming together to redefine how digital interactions blend with the physical environment and how people work, learn, and interact with information.Focusing on Compact Form and Enhanced Wearability in Fundamental DesignNew developments focus on crafting lighter, more wearable AR glasses that resemble everyday eyewear far more closely. Earlier headsets tended to be bulky and demanded substantial power, which hindered their widespread use. Current versions highlight better weight distribution,…

Digital biomarkers refer to objective and measurable physiological and behavioral information gathered via digital devices, including smartphones, wearable sensors, and connected medical instruments. In contrast to traditional biomarkers that typically depend on lab evaluations or in‑clinic assessments, digital biomarkers are produced continuously within everyday environments. They capture indicators such as heart rhythms, activity levels, sleep behaviors, vocal attributes, typing patterns, and movement dynamics, turning routine interactions with technology into meaningful health insights.Shifting from Occasional Treatment to Ongoing MonitoringConventional health checkups usually occur sporadically through infrequent clinic appointments and brief diagnostic evaluations, while digital biomarkers move this approach toward ongoing monitoring.…

Zero-knowledge proofs, or ZKPs, first emerged within academic cryptography and later entered the public spotlight through blockchain technology and privacy-driven cryptocurrencies. Their fundamental appeal lies in a remarkable idea: a party can verify the truth of a claim without disclosing the data that substantiates it. As organizations confront increasing demands to safeguard confidential information, meet rigorous regulatory requirements, and still operate collaboratively across different entities, this approach is becoming valuable well beyond digital asset ecosystems.A practical view of zero-knowledge proofsAt an enterprise level, ZKPs enable verifiable trust with minimal disclosure. Instead of sharing raw data, organizations can share proofs that…